📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 18:10
510 analysed today
510
Today
133,399
All-time analysed
40,108
Positive
6,279
Negative
79,197
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
25 announcements match the current filters (relevance ≥ 5).
AARTIIND Q1 FY27: 260% PAT Growth to ₹155 Cr; ₹700-800 Cr FY27 Capex on Track
Aarti Industries reported a robust Q1 FY27 with revenue growing 41% YoY to ₹2,627 crore and PAT surging 260% to ₹155 crore, driven by product mix optimization and inventory gains. Despite a significant drop in West Asia revenue share from 15% to 2% due to regional conflict, the company successfully redirected volumes to other markets. Management maintained its FY27 capex guidance of ₹700-800 crore, with ₹180 crore already deployed in Q1. Key growth projects, including the Zone 4 expansion, face minor 3-6 month delays but remain slated for phased commissioning within FY27.
Confidence: HIGH
What changedThe company has successfully navigated geopolitical disruptions by redirecting export volumes and is transitioning from a high-capex phase to a high-growth execution phase.
Why it mattersThe strong earnings growth despite high raw material costs (Benzene, Aniline) and regional conflicts demonstrates operational resilience and the ability to pass through costs in core segments.
Q1 FY27 Revenue: ₹2,627 crQ1 FY27 PAT Growth (YoY): 260%FY27 Capex Guidance: ₹700-800 crFuel Additives Capacity: 360 KTPACapex vs TTM Revenue: ~9.6%
📅 Short termPositive momentum is expected due to the significant earnings beat and EBITDA growth, though high working capital requirements from elevated feedstock prices remain a factor to watch.
📈 Long termStructural growth is supported by capacity expansions in Zone 4 and fuel additives, alongside new JVs in specialty chemicals and plastic recycling, aiming for higher margins post-FY27.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical conflict in West Asia impacting export logistics
- 3-6 month delays in major project commissioning
- High raw material price volatility (Benzene, Sulphur, Methanol)
Key Highlights
Q1 FY27 PAT surged 260% YoY to ₹155 crore, while EBITDA grew 79% to ₹385 crore.
Fuel additives capacity expanded from 290 KTPA to 360 KTPA to diversify geographic reach.
FY27 Capex guidance maintained at ₹700-800 crore, representing approximately 9.6% of TTM revenue.
West Asia revenue contribution fell sharply to 2% from 15% due to geopolitical tensions.
Zone 4 project commissioning expected in FY27 with a 3-6 month delay due to labor and war-related issues.
👀 What to Watch
Investors should monitor the commissioning of the Augene Chemicals JV in Q2 FY27 and the execution timeline of the Zone 4 project, as these are critical for volume ramp-up in FY28 and FY29.
57% YoY Revenue Growth in Q1 FY27; Fuel Additive Capacity Reaches 360 kTPA
Aarti Industries reported a strong YoY performance for Q1 FY27 with revenue growing 57% to ₹2,422 Cr, although it declined 17% sequentially due to West Asia supply chain disruptions. Profitability saw a sharp jump with PAT up 260% YoY, supported by inventory monetization and FX gains. The company successfully expanded its fuel additive capacity from 290 to 360 kTPA in July 2026. However, management noted a 2-quarter delay in Zone IV projects and a significant drop in Middle East revenue contribution from 15% to 2% due to regional conflict.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and provided an update on its capacity expansion roadmap, including the completion of a fuel additive unit and delays in other major projects.
Why it mattersThe expansion in fuel additives (now 38% of revenue) is a key growth driver, while the FY28 EBITDA guidance suggests a significant planned scale-up from the current TTM EBITDA of approximately ₹1,166 Cr.
Q1 FY27 Revenue: ₹2422 CrYoY Revenue Growth: 57%Fuel Additive Capacity: 360 kTPAMiddle East Revenue Share: 2%FY28 EBITDA Target: ₹1800 - 2200 CrQ1 Revenue vs TTM Revenue: ~29%
📅 Short termThe strong YoY profit growth and capacity completion are positive signals, though the sequential revenue decline and project delays may temper immediate stock momentum.
📈 Long termThe structural shift toward energy additives and the FY28 EBITDA target indicate a clear growth trajectory, provided the company can navigate geopolitical risks and project execution delays.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical risk (West Asia conflict impacting 13% of historical revenue)
- Project execution delays (Zone IV delayed by 2 quarters)
- Chinese dumping and global pricing pressure on margins
Key Highlights
Revenue for Q1 FY27 stood at ₹2,422 Cr, representing a 57% YoY increase but a 17% QoQ decline.
Fuel additive capacity (Methylation) expanded from 290 to 360 kTPA as of July 2026.
Middle East revenue share plummeted to 2% from a historical ~15% due to the West Asia conflict.
Management set a long-term EBITDA target of ₹1,800-2,200 Cr by FY28.
Zone IV projects at Jhagadia are delayed by 2 quarters due to labor constraints and geopolitical issues.
👀 What to Watch
Monitor the volume ramp-up in the newly expanded 360 kTPA fuel additive segment and the execution of delayed Zone IV projects in FY27. Investors should also track the company's ability to maintain margins (currently 12-14%) amidst Chinese dumping and high input costs.
Aarti Industries to Incorporate 100% Wholly Owned Subsidiary in China
Aarti Industries' Board approved the incorporation of a wholly owned subsidiary in China on July 30, 2026. This strategic move comes as the company manages a TTM revenue of Rs 8,300 Cr and navigates significant headwinds, including 50% US tariffs on products representing 15-20% of its revenue. While the specific capital outlay was not disclosed, the move likely aims to strengthen the company's supply chain or market presence in a region that currently exerts pricing pressure through dumping. Investors should note the company's current debt level of Rs 4,965 Cr and an OPM of 14.0%.
Confidence: MEDIUM
What changedThe company has formally decided to establish a legal corporate presence in China through a new wholly owned subsidiary.
Why it mattersEstablishing a base in China is a strategic move to potentially mitigate supply chain risks or better compete in a market that is currently a major source of pricing pressure and dumping in the chemicals sector.
Subsidiary Ownership: 100%TTM Revenue: Rs 8300 CrRevenue exposed to US Tariffs: 15-20%Total Debt: Rs 4965 Cr
📅 Short termNeutral; the announcement is a preliminary board approval with no immediate impact on cash flows or operations.
📈 Long termPotentially strategic for supply chain integration or market expansion, though it introduces exposure to Chinese regulatory and geopolitical risks.
⚠ Risk flags
- Geopolitical risks
- Regulatory compliance in a foreign jurisdiction
- Lack of initial financial disclosure regarding investment size
Key Highlights
Board approved the incorporation of a 100% wholly owned subsidiary in China on July 30, 2026.
Company currently faces 50% US tariffs on products contributing 15-20% of total revenue.
TTM revenue stands at Rs 8,300 Cr with a net profit of Rs 419 Cr as of FY26.
Operating profit margins (OPM) are currently at 14.0% amid global pricing pressures.
👀 What to Watch
Monitor subsequent filings for the 'Additional Information' disclosure to understand the subsidiary's capital commitment and whether its focus is on manufacturing, sourcing, or trading.
260% PAT Growth in Q1 FY27; Fuel Additive Capacity Expanded to 360 KTPA
Aarti Industries reported a strong start to FY27 with revenue growing 41% YoY to ₹2,627 crore and PAT surging 260% YoY to ₹155 crore. EBITDA grew 79% YoY to ₹385 crore, driven by an optimized product mix and inventory gains despite volume degrowth in some segments. The company successfully expanded its Fuel Additives capacity from 290 KTPA to 360 KTPA in July 2026. However, key expansion projects in Zone IV and chlorotoluene value chains are facing a 4-6 month delay due to labor constraints.
Confidence: HIGH
What changedAarti Industries delivered a significant earnings beat with 260% PAT growth and completed a 24% capacity expansion in its fuel additives segment.
Why it mattersThe strong margin recovery and capacity expansion signal resilience against global supply chain headwinds and support the company's shift toward high-value specialty chemicals.
Revenue (Q1 FY27): ₹2627 crorePAT Growth (YoY): 260%Fuel Additive Capacity: 360 KTPAFY27 Capex Guidance: ₹700-800 croreQ1 Capex vs TTM Revenue: ~2.17%
📅 Short termThe stock may react positively to the sharp recovery in profitability and the successful capacity expansion in fuel additives.
📈 Long termStructural growth is supported by the ramp-up of new capacities and entry into energy additives, though high debt (D/E 0.83) and project delays remain key monitorables.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Labor constraints causing 4-6 month delays in key projects
- Geopolitical tensions in West Asia impacting export volumes
- High debt-to-equity ratio of 0.83
Key Highlights
Revenue from operations increased 41% YoY to ₹2,627 crore for Q1 FY27.
Profit After Tax (PAT) surged 260% YoY to ₹155 crore.
Fuel Additives capacity successfully expanded from 290 KTPA to 360 KTPA in July 2026.
FY27 Capex guidance maintained at ₹700–800 crore, with ₹180 crore spent in Q1.
Zone IV expansion and chlorotoluene projects delayed by 4-6 months due to labor constraints.
👀 What to Watch
Monitor the commissioning of the MPP plants in Q2 FY27 and the volume recovery in the Energy business following West Asia disruptions. Track the execution of the Zone IV expansion, which is now phased over the next three quarters.
Aarti Industries to Incorporate Wholly Owned Subsidiary in China
Aarti Industries' Board of Directors approved the incorporation of a 100% wholly owned subsidiary in China on July 30, 2026. This strategic move occurs while the company manages a TTM revenue of ₹8,300 Cr and faces margin pressure from Chinese dumping and 50% US tariffs on 15-20% of its revenue. Specific investment amounts and business objectives for the new entity were not disclosed in the initial filing. Investors should note that further details are expected once the incorporation process is finalized.
Confidence: MEDIUM
What changedAarti Industries is establishing a formal corporate presence in China, moving from a purely competitive/export relationship to having a local subsidiary.
Why it mattersEstablishing a base in China could help the company mitigate supply chain risks or better navigate the 'Chinese dumping' that currently limits its pricing power and keeps margins in the 12-14% range.
Ownership Stake: 100%TTM Revenue: ₹8300 CrUS Tariff Exposure: 15-20% of revenueBoard Approval Date: July 30, 2026
📅 Short termNeutral impact expected in the immediate term as the filing lacks financial specifics regarding capital outlay.
📈 Long termPotentially significant for supply chain integration or market access, though it introduces geopolitical and regulatory risks inherent to operating in China.
⚠ Risk flags
- Geopolitical risk
- Regulatory compliance in China
- Potential for capital misallocation
Key Highlights
Board approval for 100% wholly owned subsidiary in China granted on July 30, 2026
Company currently manages ₹8,300 Cr TTM revenue with a 14% operating margin
Move comes amid 50% US tariffs impacting 15-20% of the company's revenue base
Strategic recalibration follows reported margin compression due to global pricing pressure
👀 What to Watch
Watch for the follow-up disclosure regarding the subsidiary's authorized capital and specific business activities (e.g., manufacturing vs. trading) to assess the scale of investment relative to the ₹17,613 Cr market cap.
AARTIIND Q1 FY27: PAT Surges 260% to ₹155 Cr; Revenue Up 41% to ₹2,627 Cr
Aarti Industries delivered a strong Q1 FY27 with revenue reaching ₹2,627 crore, a 41% YoY increase and significantly higher than the previous quarter's ₹2,205 crore. PAT grew 260% YoY to ₹155 crore, driven by an optimized product mix and inventory gains despite geopolitical disruptions in West Asia. While EBITDA grew 79% YoY to ₹385 crore, the company reported a 4-6 month delay in its Zone IV and chlorotoluene projects due to labor constraints. Fuel additive capacity was successfully expanded by 24% to 360 KTPA in July 2026.
Confidence: HIGH
What changedThe company has demonstrated a sharp recovery in profitability and revenue growth compared to FY26 levels, alongside a successful capacity expansion in fuel additives.
Why it mattersThe results indicate strong operating leverage and the ability to pass on costs/manage inventory despite global headwinds, though persistent project delays could slow the long-term growth trajectory.
Q1 Revenue: ₹2627 crorePAT Growth (YoY): 260%EBITDA Growth (YoY): 79%Fuel Additives Capacity: 360 KTPAQ1 Revenue vs TTM Revenue: 31.6%FY27 Capex Guidance: ₹700-800 crore
📅 Short termThe stock is likely to react positively to the significant YoY earnings beat and the 13% QoQ EBITDA growth.
📈 Long termStructural growth is supported by the shift toward energy additives (now 36% of revenue) and ongoing expansions, though high debt and execution delays remain long-term monitoring points.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- 4-6 month delay in key expansion projects (Zone IV)
- Geopolitical tensions in West Asia impacting energy business volumes
- High debt-to-equity ratio of 0.83
Key Highlights
Revenue of ₹2,627 crore represents approximately 31.6% of the total TTM revenue in a single quarter.
PAT surged 260% YoY to ₹155 crore, compared to ₹43 crore in the same quarter last year.
Fuel Additives capacity increased from 290 KTPA to 360 KTPA as of July 2026.
FY27 Capex guidance maintained at ₹700–800 crore, with ₹180 crore already deployed in Q1.
Zone IV and chlorotoluene projects face a 4-6 month delay, now expected to commission over the next three quarters.
👀 What to Watch
Investors should monitor the volume recovery in Q2 FY27 as guided by management and track the commissioning timeline of the MPP plants. The 4-6 month delay in Zone IV projects is a key execution risk to watch regarding FY27-28 growth targets.
Aarti Industries shifts to professional management; CEO Suyog Kotecha appointed MD
Aarti Industries has announced a significant leadership transition effective October 1, 2026, moving from a promoter-led to a professional-led management structure. Current CEO Suyog Kotecha will assume the role of Managing Director for a 5-year term, while three promoter directors—Rajendra, Rashesh, and Renil Gogri—will transition from Executive to Non-Executive roles. The promoters will continue to provide strategic oversight as Chairman and Vice-Chairmen. This transition occurs as the company manages a ₹8,300 Cr revenue base and navigates global margin pressures.
Confidence: HIGH
What changedThe company is transitioning its top executive leadership from the promoter family to a professional Managing Director, effective October 1, 2026.
Why it mattersThis signals a maturing governance model for a ₹17,613 Cr market cap company, potentially improving operational agility while retaining promoter strategic guidance during a period of high debt (₹4,965 Cr).
Effective Date of Change: October 1, 2026MD Appointment Term: 5 yearsTTM Revenue: ₹8,300 CrPromoter Holding: 42.1%Debt-to-Equity Ratio: 0.83
📅 Short termThe market is likely to view the structured succession plan positively as it removes uncertainty regarding leadership continuity.
📈 Long termStructural shift toward professional management could lead to better capital allocation and operational efficiencies as the company targets FY27 capacity commercialization.
⚠ Risk flags
- Potential for strategic friction between professional MD and non-executive promoter chairmen
- Execution risk during the transition period
Key Highlights
Transition of 3 promoter directors to Non-Executive roles effective October 1, 2026
Appointment of current CEO Suyog Kotecha as Managing Director for a 5-year term
Promoter holding remains stable at 42.1% as of March 2026
Transition aligns with a ₹8,300 Cr TTM revenue scale and 14% OPM environment
Board meeting for these approvals concluded at 6:30 pm on July 30, 2026
👀 What to Watch
Watch for the smooth handover of operational responsibilities by October 2026 and monitor if the professional leadership can improve the current 7% ROCE through better capacity utilization.
₹155 Cr PAT (+260% YoY); Revenue up 42% in Q1 FY27 Results
Aarti Industries reported a strong start to FY27 with consolidated net revenue growing 42.4% YoY to ₹2,387 Cr. Net profit surged 260% YoY to ₹155 Cr, significantly exceeding the ₹43 Cr reported in the same quarter last year. This growth was achieved despite a 38% YoY increase in finance costs to ₹83 Cr. The company also completed the divestment of its subsidiary Shanti Intermediates for ₹2 Cr, which had a negligible impact on overall operations.
Confidence: HIGH
What changedAarti Industries has shown a sharp recovery in profitability and volume-led revenue growth compared to the low base of the previous year.
Why it mattersThe results indicate strong operating leverage and volume ramp-up, which are critical to offset global pricing pressures and high interest expenses from its ₹4,965 Cr debt.
Consolidated Net Revenue: ₹2,387 CrNet Profit (PAT): ₹155 CrRevenue Growth (YoY): 42.4%Finance Costs: ₹83 CrEPS (Basic): ₹4.27
📅 Short termThe stock is likely to react positively to the significant YoY profit growth and sequential improvement in margins.
📈 Long termLong-term value depends on the successful execution of the energy additives segment and navigating the 'Negative' credit rating outlook through debt reduction or earnings growth.
⚠ Risk flags
- High finance costs (₹83 Cr per quarter)
- Negative credit rating outlook from CRISIL/India Ratings
- Exposure to 50% US tariffs on 15-20% of revenue
Key Highlights
Consolidated Net Revenue increased 42.4% YoY to ₹2,387 Cr from ₹1,676 Cr
Net Profit (PAT) jumped 260.5% YoY to ₹155 Cr compared to ₹43 Cr in Q1 FY26
Finance costs rose to ₹83 Cr from ₹60 Cr in the previous year's quarter
Divested 100% stake in Shanti Intermediates Private Limited for ₹2 Cr on June 23, 2026
Outstanding Commercial Papers (Short Term Debt) stood at ₹600 Cr as of June 30, 2026
👀 What to Watch
Watch for the commercialization of Zone 4 Jhagadia capacities in FY27 and the management's commentary on mitigating the 50% US tariff impact on 15-20% of revenue.
Aarti Industries Promoters Confirm Zero Share Encumbrance for FY 2025-26
Chandrakant Vallabhaji Gogri, representing the promoter group of Aarti Industries Limited, has submitted a formal declaration under SEBI (SAST) Regulations. The disclosure confirms that none of the promoters or promoter group members have encumbered their shares, directly or indirectly, during the financial year 2025-2026. This annual declaration covers a comprehensive list of 145 entities, including individual promoters, family trusts, and corporate bodies. Such transparency ensures that promoter holdings remain unpledged, reducing risks associated with margin calls or forced liquidations.
Key Highlights
Promoter group confirms zero encumbrance on shares for the entire Financial Year 2025-2026.
Declaration submitted in compliance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The disclosure encompasses a total of 145 promoter and promoter group entities, including major trusts and subsidiaries.
Confirmation indicates that no promoter shares were pledged as collateral for loans during the period.
👀 What to Watch
Investors can take comfort in the fact that 100% of the promoter holding remains unencumbered, which is a sign of financial stability. No immediate action is required as this is a routine but positive annual compliance filing.
Aarti Industries Achieves EcoVadis Platinum Rating 2026 with 87/100 Score
Aarti Industries has secured the prestigious EcoVadis Platinum Rating for 2026, placing it in the top 1% of companies evaluated globally. The company's sustainability score improved significantly to 87/100, up from 78 in the previous assessment and 38 in 2017. Furthermore, its S&P Global CSA score rose to 78 from 62, ranking it in the 98th percentile of the global chemical sector. These achievements reinforce Aarti's position as a 'Partner of Choice' for global customers who increasingly prioritize ESG-compliant supply chains.
Key Highlights
Achieved EcoVadis Platinum Rating with a score of 87/100, ranking in the top 1% of companies globally.
Sustainability score has seen a 49-point improvement over the last decade, rising from 38 in 2017 to 87 in 2026.
S&P Global CSA score increased to 78 from 62, placing the company in the 98th percentile of the chemical sector.
One of only 37 chemical companies globally included in the S&P Global Sustainability Yearbook 2026.
Highest CSA score among the seven Indian chemical firms included in the Sustainability Yearbook.
👀 What to Watch
Investors should recognize this as a significant competitive advantage that strengthens the company's relationship with global MNCs and may attract ESG-focused institutional capital. The consistent improvement in sustainability metrics reflects high operational standards and long-term risk management maturity.
Aarti Industries Q4 FY26 PAT Jumps 43% to ₹137 Cr; FY27 Capex Guided at ₹700-800 Cr
Aarti Industries reported a robust Q4 FY26 with PAT growing 43% Y-o-Y to ₹137 crore and revenue increasing 9% to ₹2,422 crore. The company demonstrated resilience against geopolitical tensions in the Middle East, which accounts for 9-10% of revenue, by rerouting volumes to other geographies. Management has signaled a shift toward capital efficiency, guiding for a lower capex of ₹700-800 crore in FY27 compared to ₹1,125 crore in FY26. Additionally, the company secured a significant $150 million multi-year supply agreement and a new backward integration contract.
Key Highlights
Q4 FY26 EBITDA grew 29% Y-o-Y to ₹342 crore, while full-year FY26 PAT rose 27% to ₹419 crore.
Secured a $150 million multi-year supply agreement for a critical agrochemical intermediate through March 2030.
Capex for FY27 is projected to decrease to ₹700-800 crore, focusing on high-return niche projects and debt reduction.
Raw material prices for benzene, sulfur, and aniline surged by over 60%, impacting input cost structures.
Zone IV projects, including multipurpose and PEDA plants, are expected to commission in phased stages during FY27.
👀 What to Watch
Investors should take confidence in the company's ability to maintain volume growth and secure long-term contracts despite global volatility. The planned reduction in capex intensity and focus on debt reduction are positive indicators for future free cash flow and return ratios.
Aarti Industries Q4 FY26: Targets ₹1,800-2,200 Cr EBITDA by FY28; MMA Volumes Surge 93% YoY
Aarti Industries reported robust volume growth in Q4 FY26, led by a 93% YoY increase in MMA and 41% in Ethylation, although agrochemical margins remain under pressure. The company has outlined a clear growth roadmap with an EBITDA target of ₹1,800-2,200 Cr by FY28 and a planned FY26 capex of ₹1,125 Cr. Despite a 3-4 month delay in Zone IV projects, the company secured a significant 4-year contract worth $150 million. Finance costs were impacted by a ₹39 Cr forex revaluation, but management aims to keep Debt/EBITDA below 2.5x while targeting over 15% ROCE.
Key Highlights
MMA production volumes grew 93% YoY in Q4 FY26, with capacity expansion to 360 kTPA currently underway.
Signed a new 4-year supply contract with a target revenue of $150 million with an existing customer.
FY26 Capex reached ₹1,125 Cr, focusing on Zone IV, Chlorotoluene, and Multi-Purpose Plant (MPP) projects.
Targeting long-term EBITDA of ₹1,800-2,200 Cr with a Debt/EBITDA ratio of less than 2.5x.
Finance costs included a ₹39 Cr impact from the revaluation of unhedged foreign currency long-term loans.
👀 What to Watch
Investors should focus on the successful ramp-up of new capacities in MMA and Ethylation which are driving volume growth. The long-term EBITDA guidance and high ROCE targets suggest strong recovery potential as agrochemical margins stabilize.
Aarti Industries FY26 PAT Jumps 27% to ₹419 Cr; Secures $150M Global Contract
Aarti Industries reported a resilient performance for FY26 with revenue growing 12% YoY to ₹9,018 Cr and PAT increasing 27% to ₹419 Cr. Despite geopolitical tensions in the Middle East affecting logistics, Q4 EBITDA rose to ₹342 Cr from ₹323 Cr in the previous quarter. The company secured a significant $150 million multi-year supply agreement and initiated a ₹200-250 Cr backward integration project. However, Q4 profitability was slightly impacted by a ₹39 Cr foreign exchange revaluation loss due to INR depreciation.
Key Highlights
Full-year FY26 Revenue reached ₹9,018 Cr, marking a 12% YoY growth.
Annual PAT stood at ₹419 Cr, a significant 27% increase compared to the previous year.
Signed a $150 million multi-year supply agreement for agrochemical intermediates through March 2030.
Q4 EBITDA improved to ₹342 Cr vs ₹323 Cr in Q3 FY26, despite macro headwinds.
Allocated ₹200–250 Cr for a strategic backward integration project under a 15-year contract.
👀 What to Watch
Investors should take confidence in the company's ability to secure long-term high-value contracts and its 27% PAT growth. While Middle East volatility remains a watchpoint for logistics costs, the improving EBITDA run rate and strategic integration projects support a positive long-term outlook.
Aarti Industries Q4 Net Profit Jumps 43% to ₹137 Cr; Recommends ₹1 Dividend
Aarti Industries reported a strong performance for Q4 FY26, with consolidated net profit rising 42.7% year-on-year to ₹137 crore. Consolidated revenue from operations grew by 13.2% to ₹2,206 crore compared to ₹1,949 crore in the same quarter last year. For the full year FY26, the company achieved a net profit of ₹419 crore on a revenue of ₹8,286 crore. The Board has recommended a dividend of ₹1 per share (20% of face value), reflecting steady shareholder returns.
Key Highlights
Consolidated Net Profit for Q4 FY26 increased to ₹137 crore from ₹96 crore in Q4 FY25.
Full-year FY26 Consolidated Revenue grew 14% to ₹8,286 crore from ₹7,269 crore.
Operating margins improved significantly to 14.15% in Q4 FY26 from 11.89% in Q4 FY25.
Board recommended a final dividend of ₹1 per equity share of face value ₹5.
Consolidated EPS for the full year FY26 rose to ₹11.56 from ₹9.13 in the previous year.
👀 What to Watch
The robust double-digit growth in both top-line and bottom-line, coupled with margin expansion, indicates a strong recovery in the specialty chemicals segment. Investors should monitor the sustainability of these margins in upcoming quarters while maintaining a positive outlook on the stock.
Aarti Industries Q4 FY26 Consolidated Net Profit Jumps 43% to ₹137 Cr; ₹1 Dividend Declared
Aarti Industries reported a strong set of results for Q4 FY26, with consolidated net profit rising 42.7% YoY to ₹137 crore. Consolidated revenue for the quarter grew 13.2% YoY to ₹2,206 crore, supported by improved operating margins which rose to 14.15% from 11.89% in the year-ago period. For the full financial year 2025-26, the company recorded a 26.6% growth in net profit to ₹419 crore. The board has recommended a final dividend of ₹1 per share, representing 20% of the face value.
Key Highlights
Consolidated Net Profit for Q4 FY26 increased to ₹137 crore, up 42.7% from ₹96 crore in Q4 FY25.
Full-year FY26 consolidated revenue reached ₹8,286 crore, a 14% growth over FY25's ₹7,269 crore.
Operating margins expanded to 14.15% in Q4 FY26 compared to 11.89% in the corresponding quarter last year.
Board recommended a final dividend of ₹1 per equity share (20% of face value) for FY26.
Consolidated Net Debt-Equity ratio stood at 0.72 as of March 31, 2026, compared to 0.62 in the previous year.
👀 What to Watch
The strong recovery in margins and double-digit bottom-line growth are positive indicators for long-term investors. Monitor the rising debt-to-equity levels and the 'Negative' credit rating outlook for potential impacts on future finance costs.
Aarti Industries Secures USD 150 Million Supply Contract with Global Agrochemical Major
Aarti Industries has entered into a significant multi-year supply agreement with a leading global agrochemical innovator for a critical intermediate used in crop protection. The contract is valued at approximately USD 150 million and is set to run through March 31, 2030. This agreement transitions a previous annual engagement into a structured, high-volume long-term contract. It provides the company with enhanced revenue visibility and strengthens its strategic position in the global agrochemical supply chain.
Key Highlights
Total contract value estimated at approximately USD 150 million over the term.
Agreement extends through March 31, 2030, providing medium-to-long term revenue visibility.
Involves the supply of a critical agrochemical intermediate to a top-tier global innovator.
The contract represents a significant increase in volumes compared to previous annual engagements.
Awarded by an international entity with no promoter or related party interest involved.
👀 What to Watch
Investors should view this as a strong positive for long-term growth and earnings stability. Maintain a positive outlook on the stock while monitoring the company's ability to scale production to meet these increased volume requirements.
Aarti Industries Bags $150 Million Supply Contract with Global Agrochemical Major
Aarti Industries Limited (AIL) has secured a multi-year supply agreement worth approximately USD 150 million with a top global agrochemical innovator. The contract, which runs through March 31, 2030, involves the supply of a critical agrochemical intermediate used in crop protection. This agreement represents a significant volume increase over previous engagements and provides strong revenue visibility for the medium to long term. Importantly, AIL will fulfill this contract using existing capacities, requiring no incremental capital expenditure.
Key Highlights
Total contract value estimated at USD 150 million over the period ending March 2030
Agreement involves a significant increase in supply volumes compared to current annual levels
No incremental capex required as the company will utilize existing adequate manufacturing capacities
Strengthens AIL's position as a strategic partner for global agrochemical innovators
👀 What to Watch
This is a positive development that enhances long-term earnings visibility and improves capacity utilization without additional debt or investment. Investors should maintain a positive outlook as this validates the company's competitive edge in the global specialty chemicals supply chain.
Aarti Industries to Invest ₹200-250 Cr for Backward Integration in Global Supply Deal
Aarti Industries has amended a long-term supply agreement with a leading global chemical company to undertake a strategic backward integration project. The company will invest ₹200–250 crores over the next two years to manufacture a critical feedstock in-house at its Dahej SEZ facility. While the move is not expected to significantly impact topline growth, it is projected to enhance EBITDA margins through operational efficiencies. This integration will benefit the company over the remaining 15-year tenure of the existing supply contract.
Key Highlights
Planned investment of ₹200–250 crores over the next two years for upstream integration.
Transitioning to an end-to-end manufacturing model for a key feedstock previously supplied by the customer.
Expected to positively enhance EBITDA margins over the residual 15-year contract tenure.
Project to be situated at the existing Dahej SEZ location in Gujarat.
Strengthens AIL's position as a preferred integrated partner for global chemical majors.
👀 What to Watch
Investors should view this as a margin-accretive development that improves long-term profitability and supply chain control. Monitor the timely execution of the CAPEX and its impact on operating leverage in future earnings.
Aarti Industries to Invest ₹200-250 Cr for Backward Integration in Long-Term Supply Deal
Aarti Industries has amended its exclusive long-term supply agreement with a global chemical major to include backward integration for a key feedstock. The company will invest ₹200–250 crore over the next two years to set up a manufacturing facility at its Dahej SEZ site. While the move is not expected to materially impact topline growth, it is projected to enhance EBITDA margins over the remaining 15-year contract period. This strategic shift aims to optimize operating expenses and freight costs while strengthening supply chain resilience.
Key Highlights
Planned investment of ₹200–250 crore over the next two years for upstream integration
Facility to be established at the existing Dahej SEZ location in Gujarat
Transitioning to an end-to-end manufacturing model for a high-value specialty chemical intermediate
Expected to improve EBITDA margins over the residual 15-year tenure of the main agreement
Focus on opex and freight optimization through in-house manufacturing versus external sourcing
👀 What to Watch
Investors should view this as a margin-accretive development that secures long-term profitability and strengthens the company's competitive moat. Monitor the timely execution of the capex and its subsequent impact on operating margins.
Aarti Industries Q3 FY26: PAT Surges 25% Q-o-Q to ₹133 Cr; Exports Hit Record 65% of Revenue
Aarti Industries reported a strong Q3 FY26 performance with revenue growing 11% Q-o-Q to ₹2,492 crore and PAT rising 25% to ₹133 crore. Export contribution reached a record 65% of total revenue, driven by the resumption of US volumes and growth in MMA and DCB products. The company is aggressively expanding MMA capacity to 360 KT by Q4FY26 and has revised its FY26 CAPEX guidance upward to ₹1,100 crore to capture high-return opportunities. Management expects structural tailwinds from the India-US trade deal and China's 'anti-involution' strategy which is curbing chemical dumping.
Key Highlights
Revenue increased 11% Q-o-Q to ₹2,492 crore, while EBITDA rose 11% to ₹323 crore.
PAT surged 25% Q-o-Q to ₹133 crore, despite a ₹15 crore exceptional provision for the new labour code.
MMA capacity is being scaled up from 290+ KT to 360 KT by the end of Q4FY26.
Exports reached an all-time high of 65% of total revenue in both percentage and absolute terms.
FY26 CAPEX guidance increased to ₹1,100 crore from ₹1,000 crore, with FY27 CAPEX expected to be significantly lower.
👀 What to Watch
Investors should view the volume recovery in the US and the capacity expansions in MMA and DCB as positive growth catalysts. The company's pivot toward high-value advanced materials and the expected margin recovery from reduced Chinese competition make it a strong long-term pick in the specialty chemicals space.
